You are here

FAZLA KİLOLU VE ŞİŞMAN KADINLARDA BOY UZUNLUĞUNUN RİSK GÖSTERGELERİ İLE İLİŞKİSİ

THE RELATIONSHIP BETWEEN HEIGHT MEASUREMENT AND METABOLIC RISK MARKERS IN OVERWEIGHT AND OBESE WOMEN

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
ABSTRACT Objective: The aim of this study was to determine the relationship between height and cardiovascular risk markers in overweight and obese women. Materials and methods: The study group was composed of 3665 overweight or obese women with body mass index varying from 25 to 67 kg/m2. In order to determine the relationship between body height and various cardiovascular risk markers, ANOVA, unpaired-t test and chi-square tests were performed. Results: Data analyses indicated a significant positive relationship between height and weight and HDL cholesterol and an inverse relationship between height and age, serum total cholesterol, glucose, triglyceride, systolic and diastolic blood pressure. No significant relationship was found between height and uric acid, insulin and HOMA (homeostasis model assessment). Age, weight, body mass index, glucose, cholesterol, triglyceride, systolic and diastolic blood pressures were found to vary between quartiles of stature. The incidence of diabetes mellitus, hypertension, hypercholesterolemia and abdominal obesity also was found to differ significantly between quartiles of stature using ANOVAanalysis. Conclusion: These results support the suggestion that short stature may be relevant to hyperglycemia, hypertension and hypercholesterolemia. Therefore, the measurement of metabolic risk markers could be useful in clinical screening for overweight and obese women of short stature.
Abstract (Original Language): 
Amaç: K›sa boy baz› kardiyovasküler risk faktörleri ile iliflki göstermektedir. Bu çal›flma fazla kilolu ve fliflman kad› nlarda boy uzunlu¤u ile çeflitli kardiyovasküler risk faktörleri aras›ndaki iliflkiyi araflt›rmak amac›yla gerçeklefltirildi. Gereç ve yöntem: Beden kitle indeksi 25-67 kg/m2 aras›nda de¤iflen 3665 fazla kilolu ve fliflman kad›nda boy ile serum glukoz, ürik asit, total ve HDL-kolesterol, trigliserit, insülin, HOMA (homeostasis model assessment), sistolik ve diyastolik damar bas›nc› aras›ndaki iliflki, korelasyon analizi ve boy uzunlu¤una göre ayr›lm›fl dört grupta ANOVA, efllenmemifl seri t-testi ve ki-kare testi ile araflt›r›ld›. Bulgular: Olgularda boy uzunlu¤u ile a¤›rl›k ve HDL kolesterol aras›nda anlaml› pozitif, boy uzunlu¤u ile yafl, beden kitle indeksi, glukoz, kolesterol, trigliserit, maksimum ve minimum damar bas›nc› ve bel-kalça oran› aras›nda anlaml› negatif iliflkiler bulundu. Boy ile ürik asit, insülin ve HOMA aras›nda anlaml› bir iliflki saptanmad›. Boy uzunlu¤una göre dört gruba ayr›lan olgularda ANOVA ile yafl, a¤›rl›k, beden kitle indeksi, glukoz, maksimum ve minimum damar bas›nc›, kolesterol, trigliserit ve bel kalça oran› aç›s›ndan gruplararas› anlaml› farklar bulundu. Vakalarda çeyrek gruplar aras›nda diabetes mellitus, hipertansiyon, hiperkolesterolemi ve abdominal fliflmanl›k varl›- ¤› bak›m›ndan anlaml› farkl›l›k bulundu. Aksine hipertrigliseridemi ve HDL-kolesterol düflüklü¤ü varl›¤› aç›s›ndan anlaml› bir fark saptanmad›. Sonuç: Bulgular›m›z, fazla kilolu ve fliflman kad›nlarda k›sa boyun hiperglisemi, hipertansiyon ve hiperkolesterolemi gibi tablolar birlikte olabilece¤ini desteklemektedir. Bu nedenle k›sa boylu ve fazla kilolu veya fliflman olan kad›nlar kardiyovasküler risk varl›¤› bak›m›ndan daha yak›ndan izlenmelidir.
9-13

REFERENCES

References: 

1. Anastasiou E, Alevizaki M, Grigorakis SJ, Philippou G, Kyprianou
M, Souvatzoglou A. Decreased stature in gestational diabetes
mellitus. Diabetologia 1998; 41: 997 – 1001.
2. Armitage P, Berry G. Statistical Methods in Medical Research,
Blackwell, Oxford, 2.Bask›, 1987.
3. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM.
Type 2 (non-insulin dependent) diabetes mellitus, hypertension
and hyperlipidemia (syndrome X). Relation to reduced fetal
growth. Diabetologia 1993; 36: 62-67.
4. Branchtein L, Schmidt MI, Matos MC, Yamashita T, Pousada
JM, Duncan BB. Short stature and gestational diabetes in Brazil.
:Brazilian Gestational Diabetes Study Group. Diabetologia
2000; 43: 848-851.
5. D’Avanzo B, La Vecchia C, Negri E: Height and the risk of acute
myocardial infarction in Italian women. Soc Sci Med 1994;
38: 193-196.
6. Davey-Smith G, Hart C, Upton M, Hole D, Gillis C, Watt G,
Hawthorne V. Height and risk of death among men and women.
Aetiological implications of associations with cardiorespiratory
disease and cancer mortality. J Epidemiol Commun Health
2000; 54: 97-103.
7. Despres JP, Prud’homme D, Pouliot MC, Tremblay A, Bouchard
C. Estimation of deep abdominal adipose tissue accumulation
from simple anthropometric measurements in men. Am J Clin
Nutr 1991; 54: 471-477.
8. Forsen T, Eriksson J, Qiao Q, Tervahauta M, Nissinen A, Tuomilehto
J. Short stature and coronary heart disease. A 35 year follow
up of the Finnish cohorts of the seven countries study. J Intern
Med 2000; 248: 326-332.
9. Haffner SM, Stern MP, Hazuda HP, Pugh J, Patterson JK. Do upper
body and centralized adiposity measure different aspects of
regional body fat distribution? Relationship to non-insulin dependent
diabetes mellitus, lipids and lipoproteins. Diabetes
1987; 36: 43-51.
10. Han TS, Feskens EJ, Lean ME, Seidell JC. Associations of body
composition with type 2 diabetes mellitus. Diabet Med 1998; 15:
129-135.
11. Houmard JA, Wheeler WS, McCammon MR, Well JM, Truitt
N, Hamad SF, Holbert D, Israel RG, Barakat HA. An evaluation
of waist to hip ratio measurement methods in relation to lipid and
carbonhydrate metabolism in men. Int J Obes 1991; 15: 181-
188.
12. Hsieh SD, Yoshinaga H. Do people with similar waist circumference
share similar health risks irrespective of height? Tohoku J
Exp Med 1999; 188: 55-60.
13. Hsieh SD, Yoshinaga H, Muto T. Waist to height ratio. Asimple
and practical index for assesing central fat distribution and me-
Fazla kilolu ve fliflman kad›nlarda boy uzunlu¤u ve risk göstergeleri
‹stanbul T›p Fakültesi Dergisi Cilt / Volume: 68 • Say› / Number: 1 • Y›l/Year: 2005
- 12 -
tabolic risk in Japanese men and women. Int J Obes Relat Metab
Disord 2003; 27: 610-616.
14. Jang HC, Min HK, Lee HK, Cho NH, Metzger BE. Short stature
in Korean women. Acontribution to the multifactorial predisposition
to gestational diabetes mellitus. Diabetologia 1998; 41:
778-783.
15. Kannam JP, Levy D, Larson MG, Wilson PW. Short stature and
risk for cardiovascular disease morbidity and mortality. The Framingham
Heart Study. Circulation 1994; 90: 224-227.
16. Kopuz K, Özbey N, Kazanc›o¤lu R, Orhan Y. fiiflman kad›nlarda
kardiyovasküler riskin saptanmas›nda bel çevresi/boy oran›
düzeyleri. Ist T›p Fak Mecm 2000; 63: 256-259.
17. Kousta E, Lawrence NJ, Penny A, Millauer BA, Robinson S,
Johnston DG, McCarthy MI. Women with a history of gestational
diabetes of European and South Asian origin are shorter
than women with normal glucose tolerance in pregnancy. Diabet
Med 2000; 17: 792-797.
18. Morris JN, Kagan A, Pattison DC, Gardner MJ. Incidence and
prediction of ischaemic heart disease in London busmen. Lancet
1966; 2: 553-559.
19. Nie NH, Hull CM, Jenkins JG, Steinbrennar K, Benta DM. Statistical
Package of the Social Sciences, McGraw Hill, New York,
2.Bask›, 1975.
20. Njolstad I, Arnesen E, Larsen PGL. Body height, cardiovascular
risk factors and risk of stroke in middle aged men and women.
A 14 year follow-up of the Finnmark study. Circulation 1996;
94: 2877-2882.
21. Norusis MJ. SPSS/PC+ for the IBM PC/XT/AT. SPSS Inc, Chicago,
1986
22. Olatunbosun ST, Bella AF. Relationship between height, glucose
intolerance and hypertension in an urban African black adult
pqopulation. Acase for the "thrifty phenotype" hypothesis. J Natl
Med Assoc 2000; 92: 265-268.
23. Rich-Edwards JW, Manson JE, Stampfer MJ, Colditz GA, Willett
WC, Rosner B, Speizer FE, Hennekens CH: Height and the
risk of cardiovascular disease in women. Am J Epidemiol 1995;
142: 909-917.
24. Rich-Edwards JW, Stampfer MJ, Manson JE, Rosner B, Hankinson
SE, Colditz, GA, Willett WC, Hennekens CH. Birth
weight and risk of cardiovascular disease in a cohort of women
followed up since 1976. BMJ 1997; 315: 396-400.
25. Özbey N, Molval›lar S, Sencer E, Orhan Y. fiiflman kad›nlarda
metabolik risk göstergesi olarak boy uzunlu¤unun de¤eri. Ist T›p
Fak Mecmuas› 2001; 64:69-73.
26. Seidell JC, Björntorp P, Sjöström L, Sannerstedt R, Krotkiewski
M, Kvist H. Regional distribution of muscle fat mass in men.
New insight into the risk of abdominal obesity using computed
tomography. Int J Obes 1989; 13: 289-295.
27. Sichieri R, Siqueira KS, Pereira RA, Ascherio A. Short stature
and hypertension in the city of Rio de Janeiro, Brazil. Public Health
Nutr 2000; 3: 77-82.
28. Smith GD, Shipley MJ, Rose G. Magnitude and causes of socioeconomic
differentials in mortality. Further evidence from the
Whitehall Study. J Epidemiol Commun Health 1990; 44: 265-
270.
29. Wamala SP, Mittleman MA, Horsten M, Schenck-Gustafsson K,
Orth-Gomer K. Short stature and prognosis of coronary heart disease
in women. J Intern Med 1999; 245: 557-563.

Thank you for copying data from http://www.arastirmax.com